WallStreetZenWallStreetZen

NASDAQ: PPCB
Propanc Biopharma Revenue

OverviewEarningsRevenue
DividendOwnership
Propanc Biopharma revenue was $0.00 for the trailing 12 months ending Mar 31, 2025, with -85.7% growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, PPCB annual revenue was $0.0, with N/A growth year-over-year.

PPCB revenue history

Current Revenue
$0.0
Current Earnings
-$55.2M
Current Profit Margin
0%

Be the first to know when PPCB announces revenue.

PPCB Revenue History By Year

PPCB Yearly RevenuePPCB RevenuePPCB ChangePPCB Revenue Growth
2024-06-30$0.00N/AN/A
2023-06-30$0.00N/AN/A
2022-06-30$0.00N/AN/A
2021-06-30$0.00N/AN/A

1 of 1

Propanc Biopharma Revenue FAQ

What was PPCB's revenue last quarter?

Propanc Biopharma (NASDAQ: PPCB) reported Q1 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Propanc Biopharma's revenue was $0.00.

What was Propanc Biopharma's revenue in 2024?

Propanc Biopharma's annual revenue for the twelve months ending Jun 30, 2024 was $0.00, a N/A decrease year over year.

How much does Propanc Biopharma make in a day?

Based on Propanc Biopharma annual revenue for the past three years, PPCB makes an average of $0.00 per day.

What was Propanc Biopharma's annual revenue growth in the past year?

As of Q3 2025, Propanc Biopharma's revenue has grown null year over year. Propanc Biopharma's revenue in the past year totaled $0.00.

How much does Propanc Biopharma make in a year?

Propanc Biopharma's revenue by year for the past three years is:
  • Propanc Biopharma's revenue for the twelve months ending Jun 30, 2024 was $0.00, a N/A decrease year over year.
  • Propanc Biopharma's annual revenue for Jun 30, 2023 was $0.00, a N/A decrease from 2022.
  • Propanc Biopharma's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.